Eloctate is approved to help control and prevent bleeding episodes, manage bleeding during surgical procedures and prevent or reduce the frequency of bleeding episodes.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
Eloctate consists of the coagulation factor VIII molecule — historically known as antihemophilic factor — linked to a protein fragment, Fc, which is found in antibodies. The safety and efficacy of the drug was evaluated in a clinical trial of 164 patients.
More Articles on Quality:
Despite Guidelines, Antibiotics Prescribed at High Rate for Bronchitis
New Pathogen-Identification Method Leads to Cost Savings: Study
Kaiser South Sacramento Patients Potentially Exposed to Whooping Cough
